Profil
Andrew E.
Mulberg is currently SVP-Regulatory Affairs & Quality Assurance at Neurogene, Inc. since 2020.
Formerly, Dr. Mulberg was Division Deputy Director-Gastroenterology at the US Food & Drug Administration and Vice President-Regulatory Affairs at Amicus Therapeutics, Inc. Education includes an undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate from Icahn School of Medicine at Mount Sinai.
Postes actifs de Andrew Mulberg
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Andrew Mulberg
| Sociétés | Poste | Fin |
|---|---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
| AMICUS THERAPEUTICS, INC. | Conseiller Juridique Général | - |
Formation de Andrew Mulberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















